Actively Recruiting
Nigella Sativa Oil for Eczematous Otitis Externa
Led by Bezmialem Vakif University · Updated on 2026-04-21
85
Participants Needed
1
Research Sites
24 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Eczematous otitis externa is a common inflammatory condition of the external auditory canal characterized by itching, discomfort, discharge, and pain. Topical corticosteroids are widely used for treatment; however, alternative therapies with fewer side effects are of increasing interest. This study aims to compare the efficacy of Nigella sativa (black seed) oil and mometasone furoate ear drops in the treatment of eczematous otitis externa. Nigella sativa is a natural product with known anti-inflammatory and antimicrobial properties. In this randomized, controlled clinical trial, adult patients with eczematous otitis externa will be assigned to receive either Nigella sativa oil or mometasone furoate ear drops for 10 days. Clinical symptoms and inflammatory findings will be evaluated at baseline and after treatment. The objective of this study is to determine whether Nigella sativa oil is an effective and safe alternative to topical corticosteroid therapy.
CONDITIONS
Official Title
Nigella Sativa Oil for Eczematous Otitis Externa
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years and older
- Clinical diagnosis of eczematous otitis externa confirmed by otoscopic examination
- Presence of at least one symptom related to the affected ear (itching, discomfort, otorrhea, or pain)
- Willingness to participate and ability to provide written informed consent
You will not qualify if you...
- Known hypersensitivity or allergic reaction to Nigella sativa oil or mometasone furoate
- Use of topical or systemic corticosteroids or other ear medications within a defined period prior to enrollment
- Presence of acute otitis externa of infectious origin requiring antibiotic treatment
- History of ear surgery or structural abnormalities of the external auditory canal
- Severe systemic disease or condition that may interfere with study participation
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bezmialem Vakif University
Istanbul, Fatih, Turkey (Türkiye), 34093
Actively Recruiting
Research Team
N
Nazan Degirmenci, MD,Assoc. Prof.
CONTACT
M
muhammed said ekinci, resident MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here